Literature DB >> 26547217

Vitamin D-binding protein and free vitamin D concentrations in acromegaly.

Alev Eroglu Altinova1, Cigdem Ozkan2, Mujde Akturk1, Ozlem Gulbahar3, Muhittin Yalcin1, Nuri Cakir1, Fusun Balos Toruner1.   

Abstract

Free 25-hydroxyvitamin D [25(OH)D] is suggested to be important in the determination of vitamin D deficiency, since vitamin D-binding protein (VDBP) may affect total 25(OH)D levels. There are no data about free 25(OH)D concentrations in acromegaly. We aimed to investigate serum VDBP and total and free 25(OH)D levels in patients with acromegaly in comparison with control subjects. We recruited 54 patients with acromegaly and 32 control subjects who were similar according to age, gender, and body mass index. Serum VDBP levels were found to be increased in patients with acromegaly compared to control subjects [90.35 (72.45-111.10) vs. 69.52 (63.89-80.13) mg/l, p = 0.001]. There was statistically no significant difference in serum total 25(OH)D levels between the patients with acromegaly and control subjects [18.63 (13.35-27.73) vs. 22.51 (19.20-28.96) ng/ml, p = 0.05]. Free 25(OH)D levels were significantly decreased in patients with acromegaly compared to control subjects [14.55 (10.45-21.45) vs. 17.75 (15.30-23.75) pg/ml, p = 0.03]. Free 25(OH)D levels correlated positively with total 25(OH)D (p = 0.0001) and HDL cholesterol (p = 0.04) and negatively with fasting blood glucose (p = 0.04). Our findings indicate that VDBP is increased and free 25(OH)D is decreased in acromegaly, while there is no significant alteration in total 25(OH)D.

Entities:  

Keywords:  Acromegaly; Free vitamin D; Total vitamin D; Vitamin D-binding protein

Mesh:

Substances:

Year:  2015        PMID: 26547217     DOI: 10.1007/s12020-015-0789-1

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  36 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Bioavailable vitamin D in chronic kidney disease.

Authors:  Alex J Brown; Daniel W Coyne
Journal:  Kidney Int       Date:  2012-07       Impact factor: 10.612

3.  Insulin resistance indices are inversely associated with vitamin D binding protein concentrations.

Authors:  Ambika P Ashraf; Carrie Huisingh; Jessica A Alvarez; Xudong Wang; Barbara A Gower
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

Review 4.  The effect of somatostatin analogs on vitamin D and calcium concentrations in patients with acromegaly.

Authors:  Adnan Ajmal; Arezoo Haghshenas; Shirin Attarian; Maya Barake; Nicholas A Tritos; Anne Klibanski; Karen K Miller; Lisa B Nachtigall
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

5.  A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations.

Authors:  J B Schwartz; J Lai; B Lizaola; L Kane; S Markova; P Weyland; N A Terrault; N Stotland; D Bikle
Journal:  J Clin Endocrinol Metab       Date:  2014-01-31       Impact factor: 5.958

6.  Vitamin D status and metabolic syndrome in the elderly: the Rotterdam Study.

Authors:  A Vitezova; M C Zillikens; T T W van Herpt; E J G Sijbrands; A Hofman; A G Uitterlinden; O H Franco; J C Kiefte-de Jong
Journal:  Eur J Endocrinol       Date:  2014-12-02       Impact factor: 6.664

7.  Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy.

Authors:  S Takamoto; H Tsuchiya; T Onishi; S Morimoto; S Imanaka; S Mori; Y Seino; T Uozumi; Y Kumahara
Journal:  J Clin Endocrinol Metab       Date:  1985-07       Impact factor: 5.958

8.  Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship.

Authors:  Camille E Powe; Catherine Ricciardi; Anders H Berg; Delger Erdenesanaa; Gina Collerone; Elizabeth Ankers; Julia Wenger; S Ananth Karumanchi; Ravi Thadhani; Ishir Bhan
Journal:  J Bone Miner Res       Date:  2011-07       Impact factor: 6.741

9.  Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies.

Authors:  Yiqing Song; Lu Wang; Anastassios G Pittas; Liana C Del Gobbo; Cuilin Zhang; Joann E Manson; Frank B Hu
Journal:  Diabetes Care       Date:  2013-05       Impact factor: 19.112

10.  Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes.

Authors:  Anat Tsur; Becca S Feldman; Ilan Feldhammer; Moshe B Hoshen; Gil Leibowitz; Ran D Balicer
Journal:  Diabetes Care       Date:  2013-02-07       Impact factor: 19.112

View more
  11 in total

1.  Vitamin D-binding protein: one more piece in the puzzle of acromegalic osteopathy?

Authors:  G Mazziotti; F Maffezzoni; A Giustina
Journal:  Endocrine       Date:  2016-02-22       Impact factor: 3.633

Review 2.  Acromegalic osteopathy.

Authors:  G Mazziotti; F Maffezzoni; S Frara; A Giustina
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

3.  Directly measured free 25-hydroxy vitamin D levels show no evidence of vitamin D deficiency in young Swedish women with anorexia nervosa.

Authors:  Martin Carlsson; Lars Brudin; Pär Wanby
Journal:  Eat Weight Disord       Date:  2017-04-28       Impact factor: 4.652

4.  Characterization of vitamin D metabolism in active acromegaly in the setting of bolus (150,000 IU) cholecalciferol treatment.

Authors:  Alexandra A Povaliaeva; Viktor P Bogdanov; Artem Yu Zhukov; Ekaterina A Pigarova; Larisa K Dzeranova; Liudmila Ya Rozhinskaya; Galina A Mel'nichenko; Natalia G Mokrysheva
Journal:  Endocrine       Date:  2022-02-09       Impact factor: 3.633

5.  Bone histomorphometry in acromegaly patients with fragility vertebral fractures.

Authors:  L Dalle Carbonare; V Micheletti; E Cosaro; M T Valenti; M Mottes; G Francia; M V Davì
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

Review 6.  VITAMIN D BINDING PROTEIN AND 25-HYDROXYVITAMIN D LEVELS: EMERGING CLINICAL APPLICATIONS.

Authors:  Navinder K Jassil; Anupa Sharma; Daniel Bikle; Xiangbing Wang
Journal:  Endocr Pract       Date:  2017-01-17       Impact factor: 3.443

Review 7.  Vitamin D Binding Protein and the Biological Activity of Vitamin D.

Authors:  Rene F Chun; Albert Shieh; Carter Gottlieb; Vahe Yacoubian; Jeffrey Wang; Martin Hewison; John S Adams
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-24       Impact factor: 6.055

8.  Plasma biomarker proteins for detection of human growth hormone administration in athletes.

Authors:  Sock-Hwee Tan; Albert Lee; Dana Pascovici; Natasha Care; Vita Birzniece; Ken Ho; Mark P Molloy; Alamgir Khan
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

9.  Is Bioavailable Vitamin D Better Than Total Vitamin D to Evaluate Vitamin D Status in Obese Children?

Authors:  Gülin Karacan Küçükali; Özlem Gülbahar; Şervan Özalkak; Hasan Dağlı; Serdar Ceylaner; Zehra Aycan; Şenay Savaş Erdeve
Journal:  J Clin Res Pediatr Endocrinol       Date:  2021-05-20

10.  Isolation of HDL by sequential flotation ultracentrifugation followed by size exclusion chromatography reveals size-based enrichment of HDL-associated proteins.

Authors:  Jack Jingyuan Zheng; Joanne K Agus; Brian V Hong; Xinyu Tang; Christopher H Rhodes; Hannah E Houts; Chenghao Zhu; Jea Woo Kang; Maurice Wong; Yixuan Xie; Carlito B Lebrilla; Emily Mallick; Kenneth W Witwer; Angela M Zivkovic
Journal:  Sci Rep       Date:  2021-08-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.